Vanguard Fiduciary Trust
GLSI icon

Vanguard Fiduciary Trust’s Greenwich LifeSciences GLSI Stock Holding History

Vanguard Fiduciary Trust’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Buy
45,965
+1,057
+2% +$25.7K ﹤0.01% 2988
2026
Q1 		$1.08M Buy
+44,908
New +$1.17M ﹤0.01% 2883

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Vanguard Fiduciary Trust's GLSI Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Greenwich LifeSciences (GLSI) stake by 2.4% in Q2 2026, buying an estimated $25.7K and bringing the position to 45,965 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2988.

Vanguard Fiduciary Trust first reported a position in GLSI in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.08M in Q1 2026. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Vanguard Fiduciary Trust held 45,965 shares of Greenwich LifeSciences worth $1.08M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 1,057 Greenwich LifeSciences shares in Q2 2026, an estimated $25.7K.
  • Greenwich LifeSciences made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2988 holding.
  • Vanguard Fiduciary Trust first reported a position in Greenwich LifeSciences in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Greenwich LifeSciences position peaked at $1.08M in Q1 2026.
  • 58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.